Vipin K. Garg
2021
In 2021, Vipin K. Garg earned a total compensation of $2.6M as Chief Executive Officer at PharmAthene, a 83% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $289,988 |
---|---|
Option Awards | $1,326,049 |
Salary | $565,673 |
Stock Awards | $436,133 |
Other | $13,796 |
Total | $2,631,639 |
Garg received $1.3M in option awards, accounting for 50% of the total pay in 2021.
Garg also received $290K in non-equity incentive plan, $565.7K in salary, $436.1K in stock awards and $13.8K in other compensation.
Rankings
In 2021, Vipin K. Garg's compensation ranked 4,952nd out of 12,415 executives tracked by ExecPay. In other words, Garg earned more than 60.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,952 out of 12,415 | 60th |
Division Manufacturing | 2,078 out of 5,508 | 62nd |
Major group Chemicals And Allied Products | 886 out of 2,378 | 63rd |
Industry group Drugs | 793 out of 2,099 | 62nd |
Industry Pharmaceutical Preparations | 565 out of 1,549 | 64th |
Source: SEC filing on August 16, 2022.
Garg's colleagues
We found four more compensation records of executives who worked with Vipin K. Garg at PharmAthene in 2021.